Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies

Journal of Clinical Microbiology

Volumn 36, Issue 12, 1998, Pages 3579-3584

  Clark, Catherine L ^a   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL DERIVATIVE; CLARITHROMYCIN; LEVOFLOXACIN; PENICILLIN G; SULFAMETHOXAZOLE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL PNEUMONIA; DRUG SENSITIVITY; HISTOGRAM; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; OTITIS MEDIA; PRIORITY JOURNAL; QUALITY CONTROL; SINUSITIS; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; STREPTOCOCCUS PNEUMONIAE;

EID: 0031784297     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.12.3579-3584.1998     Document Type: Article

References (19)

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae - an overview. Clin. Infect. Dis. 15:77-83.
2. Block, S., J. Hedrick, P. Wright, R. Finger, R. Leggiadro, M. Appleton, S. Kahn, and R. Hutcheson. 1994. Drug-resistant Streptococcus pneumoniae -Kentucky and Tennessee, 1993. Morbid. Mortal. Weekly Rep. 43:23-25, 31.
3. 2 incubation on MICs of quinolones tested with S. pneumoniae and H. influenzae, abstr. D-35, p. 89. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
4. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliott, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
5. Doern, G. V., A. Brueggemann, H. P. Holley, Jr., and A. M. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from out-patients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:1208-1213.
6. Fasola, E. L., S. Bajaksouzian, P. C. Appelbaum, and M. R. Jacobs. 1997. Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods. Antimicrob. Agents Chemother. 41:129-134.
7. Friedland, I. R., and G. S. Istre. 1992. Management of penicillin-resistant pneumococcal infections. Pediatr. Infect. Dis. J. 11:433-435.
8. Friedland, I. R., and G. H. McCracken, Jr. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
9. Jacobs, M. R. 1992. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 15:119-127.
10. Jones, R. N., M. E. Erwin, and J. L. Croco. 1996. Critical appraisal of E test for the detection of fluoroquinolone resistance. J. Antimicrob. Chemother. 38:21-25.
11. McDougal, L. K., R. Facklam, M. Reeves, S. Hunter, J. M. Swenson, B. C. Hill, and F. C. Tenover. 1992. Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrob. Agents Chemother. 36:2176-2184.
12. Munoz, R., J. M. Musser, M. Crain, D. E. Briles, A. Marton, A. J. Parkinson, U. Sorensen, and A. Tomasz. 1992. Geographic distribution of penicillin-resistant clones of Streptococcus pneumaniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clin. Infect. Dis. 15:112-118.
13. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS publication no. M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
14. National Committee for Clinical Laboratory Standards. 1947. Performance standards for antimicrobial disk susceptibility tests. NCCLS publication no. M2-A6. National Committee for Clinical Laboratory Standards, Villanova, Pa.
15. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1995. Activity of CP 99.219 compared to DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci. J. Antimicrob. Chemother. 35:230-232.
16. Spika, J. S., R. R. Facklam, B. D. Plikaytis, M. J. Oxtoby, and the Pneumococcal Surveillance Working Group. 1991. Antimicrobial resistance of Streptococcus pneumoniae in the United States. 1974-1987. J. Infect. Dis. 163: 1273-1278.
17. Visalli, M. A., M. R. Jacobs, and P. C. Appelbaum. 1996. MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother. 40:362-366.
18. Visalli, M. A., M. R. Jacobs, and P. C. Appelbaum. 1997. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. Antimicrob. Agents Chemother. 41:1867-1870.
19. Visalli, M. A., M. R. Jacobs, and P. C. Appelbaum. 1997. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill. Diagn. Microbiol. Infect. Dis. 28:131-137.